Source link : https://www.newshealth.biz/health-news/fda-advisers-greenlight-early-car-t/
An advisory panel at the US Food and Drug Administration (FDA) lent support to bids that allow for earlier use of chimeric antigen receptor (CAR-T) therapies in treating multiple myeloma, while also calling for clear disclosure to patients of potential risks of these treatments. The FDA asked its Oncologic Drugs Advisory Committee (ODAC) to vote […]
Author : News Health
Publish date : 2024-03-21 05:45:14
Copyright for syndicated content belongs to the linked Source.